Experimental autoimmune encephalomyelitis accelerates remyelination after lysophosphatidylcholine-induced demyelination in the corpus callosum

J Neuroimmunol. 2019 Sep 15:334:576995. doi: 10.1016/j.jneuroim.2019.576995. Epub 2019 Jun 15.

Abstract

Experimental autoimmune encephalomyelitis (EAE) and lysophosphatidylcholine (LPC)-induced demyelination were combined to study remyelination in a pro-inflammatory context. Two groups of female C57BL/6 mice were subjected either to EAE (EAE mice) or injected with just complete Freund's adjuvant (CFA) and pertussis toxin (PTX) followed by bilateral LPC and phosphate buffered saline injections in the corpus callosum on day 7 (CFA controls). Relative to CFA controls, EAE accelerated remyelination and increased innate immune cell activation, lymphocyte infiltration and cytokine gene expression in the LPC lesions. However, compared to CFA mice, remyelination was reduced (day 14) suggesting this aggressive immune response also compromised myelin repair in EAE mice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Corpus Callosum / drug effects
  • Corpus Callosum / immunology*
  • Corpus Callosum / pathology
  • Demyelinating Diseases / chemically induced
  • Demyelinating Diseases / immunology*
  • Demyelinating Diseases / pathology
  • Encephalomyelitis, Autoimmune, Experimental / chemically induced
  • Encephalomyelitis, Autoimmune, Experimental / immunology*
  • Encephalomyelitis, Autoimmune, Experimental / pathology
  • Female
  • Freund's Adjuvant / toxicity
  • Immunity, Innate / drug effects
  • Immunity, Innate / immunology*
  • Lysophosphatidylcholines / toxicity*
  • Mice
  • Mice, Inbred C57BL
  • Remyelination / drug effects
  • Remyelination / immunology*

Substances

  • Lysophosphatidylcholines
  • Freund's Adjuvant